Healthcare provider profile · identity verified

Sameh Nabelsi, M.D.

Internal Medicine · FLOSSMOOR, IL · NPI 1518923515

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	416	107
Atorvastatin Calcium	Atorvastatin Calcium	367	114
Amlodipine Besylate	Amlodipine Besylate	361	111
Rosuvastatin Calcium	Rosuvastatin Calcium	354	106
Metoprolol Tartrate	Metoprolol Tartrate	247	63
Pantoprazole Sodium	Pantoprazole Sodium	232	73
Metformin Hcl	Metformin Hcl	201	57
Azithromycin	Azithromycin	194	129
Losartan Potassium	Losartan Potassium	194	57
Lisinopril	Lisinopril	182	53
Potassium Chloride	Potassium Chloride	176	52
Furosemide	Furosemide	159	46
Albuterol Sulfate Hfa	Albuterol Sulfate	149	63
Metoprolol Succinate	Metoprolol Succinate	148	45
Allopurinol	Allopurinol	144	41
Simvastatin	Simvastatin	134	39
Eliquis	Apixaban	133	30
Montelukast Sodium	Montelukast Sodium	128	37
Methylprednisolone	Methylprednisolone	120	84
Tamsulosin Hcl	Tamsulosin Hcl	117	30
Ozempic	Semaglutide	111	19
Omeprazole	Omeprazole	109	32
Gabapentin	Gabapentin	105	36
Azelastine Hcl	Azelastine Hcl	97	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	29
Fluticasone Propionate	Fluticasone Propionate	89	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	82	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	82	26
Hydrochlorothiazide	Hydrochlorothiazide	79	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	18
Alprazolam	Alprazolam	75	23
Sertraline Hcl	Sertraline Hcl	72	22
Atenolol	Atenolol	70	14
Synthroid	Levothyroxine Sodium	64	15
Valsartan	Valsartan	58	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	16
Carvedilol	Carvedilol	56	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	43
Clopidogrel	Clopidogrel Bisulfate	53	17
Jardiance	Empagliflozin	53	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	50	24
Tramadol Hcl	Tramadol Hcl	50	14
Finasteride	Finasteride	46	suppressed
Donepezil Hcl	Donepezil Hcl	42	11
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	13
Tizanidine Hcl	Tizanidine Hcl	41	26
Glipizide	Glipizide	40	11
Hydralazine Hcl	Hydralazine Hcl	39	11
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Irbesartan	Irbesartan	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	16
Warfarin Sodium	Warfarin Sodium	37	suppressed
Farxiga	Dapagliflozin Propanediol	36	11
Olmesartan Medoxomil	Olmesartan Medoxomil	36	11
Mounjaro	Tirzepatide	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	26
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Trazodone Hcl	Trazodone Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	27	24
Ventolin Hfa	Albuterol Sulfate	27	15
Amoxicillin	Amoxicillin	26	18
Metformin Hcl Er	Metformin Hcl	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Famotidine	Famotidine	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Creon	Lipase/Protease/Amylase	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Cephalexin	Cephalexin	18	14
Hydrocortisone	Hydrocortisone	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Celecoxib	Celecoxib	17	suppressed
Linzess	Linaclotide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Methimazole	Methimazole	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Prednisone	Prednisone	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Baclofen	Baclofen	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error